PD-1 inhibitor combined with chemotherapy or lenvatinib in advanced gallbladder cancer: a retrospective comparative study
Tislelizumab combined with GS chemotherapy provides a safe and more efficient treatment option for advanced GBC patients.
Authors
- Hongyan Ma (ORCID: https://orcid.org/0000-0002-0120-4502)
- Hao Song (ORCID: https://orcid.org/0000-0003-2422-4941)
- Qinwen Tai (ORCID: https://orcid.org/0009-0007-3499-0128)
Institutions
- Longgang Central Hospital (CN)
- Southern Medical University Shenzhen Hospital (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-02-24
- DOI
- https://doi.org/10.1186/s12876-025-03688-3
- Citations
- 3
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.02
Funders
- Department of Education of Guangdong Province